Is HCP Plastene overvalued or undervalued?

As of 2 June 2025, HCP Plastene's valuation grade has moved from attractive to very attractive, indicating a positive shift in its market perception. The company is currently considered undervalued. Key ratios supporting this assessment include a PE Ratio of 18.41, an EV to EBITDA of 10.34, and a PEG Ratio of 0.02, which suggests significant growth potential relative to its price.
In comparison to its peers, HCP Plastene's valuation metrics stand out; for instance, Garware Hi Tech is categorized as very expensive with a PE of 31.43, while AGI Greenpac, also very attractive, has a PE of 17.02. This positions HCP Plastene favorably within the packaging industry. Despite a recent decline in stock performance over the past week, the company has shown impressive returns over the longer term, with a staggering 4969.53% increase over the past five years, significantly outperforming the Sensex's 143.13% during the same period.